EBA concerned with rules on medical devices and in vitro diagnostics
The European Blood Alliance responded to the European Commission’s target evaluation of Regulations 2017/745 and 2017/746 on medical devices and[…]
SoHO Regulation Text
Regulation (EU) 2024/1938 on standards of quality and safety for substances of human origin intended for human application (SoHO Regulation)[…]
Presentations: Webinar Exploring the Potential of human Platelet Lysate
We are pleased to share the highlights from our recent webinar on the applications and advancements of human platelet lysate,[…]
World Blood Donor Day 2024: Thank you, blood donors!
Today the world commemorates the 20th World Blood Donor Day under the motto “20 years of celebrating giving: Thank you,[…]
EBA warmly welcomes the adoption of the SoHO regulation
Brussels, 24 April 2024 Peter O’Leary, EBA Executive Director, said “the text adopted today is a historic step forward for[…]
MSM policy and PrEP/PEP
Blood donation eligibility policies for men who have sex with men (MSM) have evolved since they were found to be[…]
CoRe SoHO warns against fragmentation of protection standards
CoRe SoHO statement on hierarchy of guidelines concerning protection of SoHO donors, recipients, and offspring As the trilogue meetings on[…]
VNRD: EBA and FIODS on future SoHO Regulation
Joint statement of EBA and IFBDO/FIODS on voluntary non-remunerated donations (VNRD) in the context of the negotiations of the future SoHO[…]
SUPPLY Newsletter
EBA is pleased to announce the inaugural edition of the SUPPLY Project Newsletter. Plasma and plasma-derived medicinal products play an[…]
EBA Position on EU Pharma Proposal
17 October 2023 General Position on the European Commission’s proposal for a reform of the EU pharmaceutical legislation The European[…]